The seAFOod Polyp Prevention Trial

Management of complications in surgery of the colon.

General surgeons are frequently confronted with colorectal diseases in their daily practice, whereby colorectal cancer is the second most common malignant tumour, with almost 5000 new cases every year in Austria. The incidence of benign colon disorders requiring surgery (e.g. colon polyps, sigmoid diverticulitis) is also increasing.

The first aim in colon surgery should be to avoid complications and if they occur to treat them properly.We basically distinguish between general and special complications.

As general complications, prevention of malnutrition and support of the immune system should receive special attention. As the number of elderly patients increases, so does the risk not only of thrombembolic complications but also of critical cardiocirculatory situations, and renal and hepatic failure.

SKT (KIAA1217) Antibody

abx234542-100g 100 µg
EUR 350

SKT (KIAA1217) Antibody

abx234542-100ug 100 ug
EUR 610.8

Mouse SKT shRNA Plasmid

20-abx980555
  • Ask for price
  • Ask for price
  • 150 µg
  • 300 µg

Mouse Sickle tail protein (SKT) ELISA Kit

abx389166-96tests 96 tests
EUR 687.5

Mouse Sickle tail protein, Skt ELISA KIT

ELI-29595m 96 Tests
EUR 1038

SKT (KIAA1217) (NM_019590) Human Over-expression Lysate

E45H11013-2 each
EUR 395

SKT (KIAA1217) (NM_019590) Human Over-expression Lysate

LS056243 100ug
EUR 960
Description: Transient overexpression lysate of KIAA1217 (KIAA1217), transcript variant 1

Recombinant Mouse Sickle tail protein (Skt) , partial

MBS1201914-INQUIRE INQUIRE Ask for price

Human Sickle tail protein homolog, SKT ELISA KIT

ELI-18163h 96 Tests
EUR 988.8

Recombinant Human Sickle tail protein homolog (SKT) , partial

MBS1296028-INQUIRE INQUIRE Ask for price

Skt ELISA Kit| Mouse Sickle tail protein ELISA Kit

EF014796 96 Tests
EUR 826.8

OM-137

406166 5.0mg
EUR 220

YC-137

406168 5.0mg
EUR 360

MNI 137

B5571-10 10 mg
EUR 428
Description: Neuroscience|GluR

MNI 137

B5571-50 50 mg
EUR 1394.4
Description: Neuroscience|GluR

BCI-137

HY-119024 10 mg
EUR 1033.57
Description: BCI-137 is a competitive AGO2 inhibitor, with an IC50 of 342 μM. BCI-137 tightly binds to several residues of the Mid domain[1].

MNI 137

MBS5757485-5mg 5mg
EUR 915

MNI 137

MBS5757485-5x5mg 5x5mg
EUR 3970

BCI-137

MBS5773544-10mg 10mg
EUR 465

BCI-137

MBS5773544-1mg 1mg
EUR 210

BCI-137

MBS5773544-5mg 5mg
EUR 335

miR-137

MO-0049 100
EUR 136

miR-137

MP-0049 20
EUR 109

miR-137

PO-0063 20
EUR 94

BCI-137

T23777-10mg 10mg Ask for price
Description: BCI-137

BCI-137

T23777-1g 1g Ask for price
Description: BCI-137

BCI-137

T23777-1mg 1mg Ask for price
Description: BCI-137

BCI-137

T23777-50mg 50mg Ask for price
Description: BCI-137

BCI-137

T23777-5mg 5mg Ask for price
Description: BCI-137

MNI 137

T23010-10mg 10mg Ask for price
Description: MNI 137

MNI 137

T23010-1g 1g Ask for price
Description: MNI 137

MNI 137

T23010-1mg 1mg Ask for price
Description: MNI 137

MNI 137

T23010-50mg 50mg Ask for price
Description: MNI 137

MNI 137

T23010-5mg 5mg Ask for price
Description: MNI 137

miR-137(HS)

HP-0063 10
EUR 182

Anticancer agent 137

HY-155570 Get quote Ask for price
Description: Anticancer agent 137 (8q) is a potent PI3k inhibitor. Anticancer agent 137 has broad-spectrum anticancer activity. Anticancer agent 137 induces G2/M cell cycle arrest and apoptosis. Anticancer agent 137 increases cleaved PARP, caspase 3, and 7. Anticancer agent 137 can be used in research of cancer[1].

ZXH-4-137

HY-132862 Get quote Ask for price
Description: ZXH-4-137 is a potent and selective CRBN degrader (PROTAC).

CD147 (BSB-137)

MBS370470-01mLConcentrate 0.1mL(Concentrate)
EUR 280

CD147 (BSB-137)

MBS370470-05mLConcentrate 0.5mL(Concentrate)
EUR 540

CD147 (BSB-137)

MBS370470-15mLRTU 15mL(RTU)
EUR 830

CD147 (BSB-137)

MBS370470-3mLRTU 3mL(RTU)
EUR 305

CD147 (BSB-137)

MBS370470-7mLRTU 7mL(RTU)
EUR 500

ZXH-4-137

MBS5800597-5mg 5(mg
EUR 915

ZXH-4-137

MBS5800597-5x5mg 5x5(mg
EUR 3970

ZXH-4-137

T40333-10mg 10mg Ask for price
Description: ZXH-4-137

ZXH-4-137

T40333-1g 1g Ask for price
Description: ZXH-4-137

ZXH-4-137

T40333-1mg 1mg Ask for price
Description: ZXH-4-137

ZXH-4-137

T40333-50mg 50mg Ask for price
Description: ZXH-4-137

ZXH-4-137

T40333-5mg 5mg Ask for price
Description: ZXH-4-137

Recombinant HAdV-2 B-137 Protein (aa 1-137)

VAng-Cr4236-1mgEcoli 1 mg (E. coli)
EUR 3688.8
Description: HAdV-2 Uncharacterized protein B-137, recombinant protein.

Recombinant HAdV-2 B-137 Protein (aa 1-137)

VAng-Cr4236-500gEcoli 500 µg (E. coli)
EUR 2650.8
Description: HAdV-2 Uncharacterized protein B-137, recombinant protein.

Recombinant HAdV-2 B-137 Protein (aa 1-137)

VAng-Cr4236-50gEcoli 50 µg (E. coli)
EUR 1825.2
Description: HAdV-2 Uncharacterized protein B-137, recombinant protein.

GPR-137 (308-324)

001-93 100 μg
EUR 282.96

VIP (125-137) (Rat)

064-15 200 μg
EUR 160.92

Sturgeon Peptide (137-158)

021-94 100 μg
EUR 177.12

RNF8 (Ab-137) Antibody

21699-100ul 100ul
EUR 302.4

RNF8 (Ab-137) Antibody

21699-50ul 50ul
EUR 224.4

HIST1H1B (Ab-137) Antibody

1-CSB-PA010377PA137nphHU
  • Ask for price
  • Ask for price
  • 100ul
  • 50ul
Description: A polyclonal antibody against HIST1H1B (Ab-137). Recognizes HIST1H1B (Ab-137) from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF; Recommended dilution: WB:1:200-1:2000, IHC:1:20-1:200

RNF8 (Ab-137) Antibody

E021699 100μg/100μl
EUR 225
Description: Available in various conjugation types.

Profilin (a.a. 126-137)

MBS474133-01mL 0.1mL
EUR 370

Profilin (a.a. 126-137)

MBS474133-5x01mL 5x0.1mL
EUR 1505

HIST1H1B (Ab-137) Antibody

MBS7106722-005mL 0.05mL
EUR 195

HIST1H1B (Ab-137) Antibody

MBS7106722-01mL 0.1mL
EUR 285

HIST1H1B (Ab-137) Antibody

MBS7106722-5x01mL 5x0.1mL
EUR 1275

rno-miR-137 Primers

MP-r00102 150 ul / 10 uM
EUR 211.2

hsa-miR-137 Primers

MPH01155 150 ul / 10 uM
EUR 145.2

mmu-miR-137 Primers

MPM00077 150 ul / 10 uM
EUR 145.2

RNF8 (Ab-137) Antibody

MBS9411285-005mL 0.05mL
EUR 245

RNF8 (Ab-137) Antibody

MBS9411285-01mL 0.1mL
EUR 305

RNF8 (Ab-137) Antibody

MBS9411285-5x01mL 5x0.1mL
EUR 1230

Tp p17 137 kDa

PR-1421-L 1mg
EUR 946.89
Description: recombinant, E. coli

Tp p17 137 kDa

PR-1421-S 200µg
EUR 236.7
Description: recombinant, E. coli

miRVec-hsa-miR-137

PPL00414-3a 412bp
EUR 218
Description: miRVec

NPDC-1 (137-176) (Human)

002-62 100 μg
EUR 355.32

p60 v-src (137-157)

5-01682 4 x 1mg
EUR 158.34
Description: Val-Ala-Pro-Ser-Asp-Ser-Ile-Gln-Ala-Glu-Glu-Trp-Tyr-Phe-Gly-Lys-Ile-Thr-Arg-Arg-Glu

RNF8 (Ab-137) Conjugated Antibody

C21699 100ul
EUR 476.4

p60 v-src (137-157)

H-8535.0500 0.5mg
EUR 254.4
Description: Sum Formula: C111H168N30O35; CAS# [131023-24-0]

p60 v-src (137-157)

H-8535.1000 1.0mg
EUR 400.8
Description: Sum Formula: C111H168N30O35; CAS# [131023-24-0]

MDM4 (1-137) recombinant protein

MBS515348-002mg 0.02mg
EUR 305

MDM4 (1-137) recombinant protein

MBS515348-005mg 0.05mg
EUR 495

MDM4 (1-137) recombinant protein

MBS515348-5x005mg 5x0.05mg
EUR 1965

hsa-miR-137 miRNA Inhibitor

MBS8292902-10nmol 10nmol
EUR 210

hsa-miR-137 miRNA Inhibitor

MBS8292902-20nmol 20nmol
EUR 265

hsa-miR-137 miRNA Inhibitor

MBS8292902-5x20nmol 5x20nmol
EUR 1110

p60 v-src (137-157)

MBS8246862-10mg 10mg
EUR 915

p60 v-src (137-157)

MBS8246862-1mg 1mg
EUR 315

p60 v-src (137-157)

MBS8246862-5mg 5mg
EUR 645

p60 v-src (137-157)

MBS8246862-5x10mg 5x10mg
EUR 4035

rno??miR-137 miRNA Antagomir

MNR01112 2 x 5.0 nmol
EUR 394.8

hsa-miR-137 miRNA Inhibitor

MIH01297 2 x 5.0 nmol
EUR 211.2

rno??miR-137 miRNA Inhibitor

MIR01112 2 x 5.0 nmol
EUR 211.2

hsa-miR-137 miRNA Antagomir

MNH01297 2 x 5.0 nmol
EUR 394.8

mmu-miR-137 miRNA Inhibitor

MIM01172 2 x 5.0 nmol
EUR 211.2

rno-miR-137-3p Primers

MPR00382 150 ul / 10 uM
EUR 211.2

rno-miR-137-5p Primers

MPR00383 150 ul / 10 uM
EUR 211.2

mmu-miR-137 miRNA Antagomir

MNM01172 2 x 5.0 nmol
EUR 394.8

mmu-miR-137-3p Primers

MPM00836 150 ul / 10 uM
EUR 145.2

mmu-miR-137-5p Primers

MPM00837 150 ul / 10 uM
EUR 145.2

RNF8 (Ab-137) Conjugated Antibody

MBS9438977-01mLAF350 0.1mL(AF350)
EUR 480

RNF8 (Ab-137) Conjugated Antibody

MBS9438977-01mLAF405 0.1mL(AF405)
EUR 480

RNF8 (Ab-137) Conjugated Antibody

MBS9438977-01mLAF488 0.1mL(AF488)
EUR 480

RNF8 (Ab-137) Conjugated Antibody

MBS9438977-01mLAF555 0.1mL(AF555)
EUR 480

RNF8 (Ab-137) Conjugated Antibody

MBS9438977-01mLBiotin 0.1mL(Biotin)
EUR 480

Recombinant BRDT (21-137) protein

MBS388164-01mg 0.1mg
EUR 585

Recombinant BRDT (21-137) protein

MBS388164-1mg 1mg
EUR 3345

Recombinant BRDT (21-137) protein

MBS388164-5x1mg 5x1mg
EUR 14870

hsa-miR-137 miRNA Mimic

MBS8298149-10nmol 10nmol
EUR 265

hsa-miR-137 miRNA Mimic

MBS8298149-5nmol 5nmol
EUR 210

hsa-miR-137 miRNA Mimic

MBS8298149-5x10nmol 5x10nmol
EUR 1110

miRVec-hsa-miR-137 Plasmid

PVTB00414-3a 2 ug
EUR 427.2

MV1LU CELLS 96 WELL/ 96 FILL

58-9696B each Ask for price
Description: flask ; Single or Mixed

CometAssay 96

4253-096-K 96 tests
EUR 513.6

Butyroin 96%

B31520 10G
EUR 176.06
Description: CAS N° 496-77-5

Benzazimide 96%

B01380 5G
EUR 78.74
Description: CAS N° 90-16-4

Diethylsilane 96%

D24635 5G
EUR 290.77
Description: CAS N° 542-91-6

Decaborane 96%

D00150 1G
EUR 264.98
Description: CAS N° 17702-41-9

Indoline 96%

I01740 100G
EUR 119.52
Description: CAS N° 496-15-1

Targaprimir-96

HY-135276 Get quote Ask for price
Description: Targaprimir-96 is a potent inhibitor of microRNA-96 (miR-96) processing. Targaprimir-96 selectively modulates miR-96 production in cancer cells and triggers apoptosis. Targaprimir-96 binds primary miR-96 (pri-miR-96) with low nanomolar affinity. Targaprimir-96 directly engages pri-miR-96 in breast cancer cells and is ineffective on healthy breast cells[1].

SP-96

HY-131339 10 mg
EUR 1071.45
Description: SP-96 is a highly potent, selective and non-ATP-competitive Aurora B (IC50=0.316 nM) inhibitor and shows >2000 fold selectivity against FLT3 and KIT. SP-96 shows selective growth inhibition in NCI60 screening, incluing MDA-MD-468 (GI50=107 nM). SP-96 can be used for the research of triple negative breast cancer (TNBC)[1].

Hexachlorodisiloxane 96%

H02650 10G
EUR 554
Description: CAS N° 14986-21-1

Hexachloropropene 96%

H02770 5G
EUR 143.51
Description: CAS N° 1888-71-7

Methyldiethoxysilane 96%

M15885 1G
EUR 103.08
Description: CAS N° 2031-62-1

Targaprimir-96

MBS5767702-5mg 5mg
EUR 915

Targaprimir-96

MBS5767702-5x5mg 5x5mg
EUR 3970

SP-96

MBS5785797-10mg 10(mg
EUR 325

SP-96

MBS5785797-1mg 1(mg
EUR 175

SP-96

MBS5785797-5mg 5(mg
EUR 245

miR-96

MO-0545 100
EUR 136

miR-96

MP-0545 20
EUR 109

Phenyldichlorosilane 96%

P10770 5G
EUR 138.28
Description: CAS N° 1631-84-1

Pinacolone 96%

P19520 25G
EUR 109.1
Description: CAS N° 75-97-8

miR-96

PO-0040 20
EUR 94

Triphenylsilane 96%

T30895 5G
EUR 119.26
Description: CAS N° 789-25-3

Tetraphenylsilane 96%

T08670 5G
EUR 227.63
Description: CAS N° 1048-08-4

Trimethylacetaldehyde 96%

T26315 5G
EUR 257.01
Description: CAS N° 630-19-3

Tetrabromocatechol 96%

T01850 5G
EUR 135.54
Description: CAS N° 488-47-1

Targaprimir-96

T13085-10mg 10mg Ask for price
Description: Targaprimir-96

Targaprimir-96

T13085-1g 1g Ask for price
Description: Targaprimir-96

Targaprimir-96

T13085-1mg 1mg Ask for price
Description: Targaprimir-96

Targaprimir-96

T13085-50mg 50mg Ask for price
Description: Targaprimir-96

Targaprimir-96

T13085-5mg 5mg Ask for price
Description: Targaprimir-96

SP-96

T41256-10mg 10mg Ask for price
Description: SP-96

SP-96

T41256-1g 1g Ask for price
Description: SP-96

SP-96

T41256-1mg 1mg Ask for price
Description: SP-96

SP-96

T41256-50mg 50mg Ask for price
Description: SP-96

SP-96

T41256-5mg 5mg Ask for price
Description: SP-96

prepro-NGF, beta (109-137) (Human)

016-13 100 μg
EUR 316.44

Peptide A / p60v-src (137-157)

058-21 500 μg
EUR 135

THT-137-499-3 AB Labels

062370 Roll of 3000 Label(s)
EUR 300.52
Description: Description Dutch: Thermische transfert labels; Description French: Etiquettes imprimables par transfert thermique

DAT-137-502-10 AB Labels

027337 Pack of 10000 Label(s)
EUR 371.03
Description: Description Dutch: DaTab Dot Matrix Beprintbare Labels; Description French: Etiquettes Dot Matrix DaTab

THT-137-7425-2 AB Labels

121011 Roll of 2000 Label(s)
EUR 127.46
Description: Description Dutch: Met thermische transfertprinter bedrukbare labels; Description French: Étiquettes imprimables par transfert thermique

STN 137-450X150-B7527 AC Signs

252351 Card of 1 Pictogram(s)
EUR 15.95
Description: Description Dutch: Verbodspictogram - Gebruik van GSM verboden; Description French: Pictogramme - Interdiction - Gebruik van GSM verboden

B33-137-7425 AF Systems Consumables

148683 Roll of 1500 Label(s)
EUR 241.48
Description: Description Dutch: Polypropyleenlabels voor de BBP33/i3300 printer; Description French: Étiquettes en polypropylène pour l’imprimante BBP33/i3300

B33-137-427AW AF Systems Consumables

143045 Box of 1500 Label(s)
EUR 183.13
Description: Description Dutch: Vinyllabels voor BBP33/i3300-printers; Description French: Étiquettes en vinyle pour imprimantes BBP33/i3300

B33-137-499 AF Systems Consumables

143066 Box of 1100 Label(s)
EUR 132.7
Description: Description Dutch: Labels uit nylonweefsel voor BBP33/i3300-printers; Description French: Étiquettes en tissu nylon pour imprimantes BBP33/i3300

Human hsa-miR-137 miRNA Agomir

abx880102-10nmol 10 nmol
EUR 575

Human hsa-miR-137 miRNA Agomir

abx880102-5nmol 5 nmol
EUR 425

p60 v-src (137-157) Peptide

abx266840-1ml 1 ml
EUR 475

p60 v-src (137-157) Peptide

abx266840-200l 200 µl
EUR 225

hsa-miR-137 miRNA Agomir/Antagomir

AM2451 2 OD, 4 OD, 50 OD (size by request, 1 OD corresponds to 33 ug) Ask for price
Description: MicroRNA: hsa-miR-137Accession Number: MIMAT0000429Mature Sequence: UUAUUGCUUAAGAAUACGCGUAGhsa-miR-137 are small non-coding RNAs of 20-22 nucleotides, typically excised from 60-110 nucleotide foldback RNA precursor structures. miRNAs are involved in crucial biological processes, including development, differentiation, apoptosis, and proliferation, through imperfect pairing with target messenger RNAs (mRNAs) of protein-coding genes and the transcriptional or post-transcriptional regulation of their expression. Click here to browse detailed information about hsa-miR-137 in miRBase.What is MicroRNA Agomir/Antagomir?MicroRNA Agomir is a special-labeled and chemically modified double-stranded small RNA that mimics the endogenous miRNA to regulate the biological function of the target gene. MicroRNA Antagomir is an especially chemically modified miRNA antagonist. It strongly competes with mature miRNAs in the body to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.Why choose hsa-miR-137 miRNA Agomir/Antagomir from Gentaur has extended experience in MicroRNA Agomir/Antagomir synthesis services that cover all human, mouse, and rat miRNAs in the current miRBase. Compared to standard miRNA mimics and inhibitors, Gentaur miRNA agomir and antagomir are more resistant to degradation, thus having a lasting effect: minimum for 1 week, up to 5-6 weeks. These products can be used in in vitro or in vivo miRNA functional studies.

Human hsa-miR-137 miRNA Antagomir

abx885349-10nmol 10 nmol
EUR 425

Human hsa-miR-137 miRNA Antagomir

abx885349-20nmol 20 nmol
EUR 575

NPDC-1 (137-176) (Human) - Antibody

H-002-62 100 μl
EUR 604.8

mmu-miR-137-5p miRNA Inhibitor

MBS8296224-10nmol 10nmol
EUR 210

mmu-miR-137-5p miRNA Inhibitor

MBS8296224-20nmol 20nmol
EUR 265

mmu-miR-137-5p miRNA Inhibitor

MBS8296224-5x20nmol 5x20nmol
EUR 1110

mmu-miR-137-3p miRNA Inhibitor

MBS8295416-10nmol 10nmol
EUR 210

mmu-miR-137-3p miRNA Inhibitor

MBS8295416-20nmol 20nmol
EUR 265

mmu-miR-137-3p miRNA Inhibitor

MBS8295416-5x20nmol 5x20nmol
EUR 1110

mmu-miR-137-5p miRNA Mimic

MBS8301471-10nmol 10nmol
EUR 265

mmu-miR-137-5p miRNA Mimic

MBS8301471-5nmol 5nmol
EUR 210

mmu-miR-137-5p miRNA Mimic

MBS8301471-5x10nmol 5x10nmol
EUR 1110

rno-miR-137-3p miRNA Antagomir

MNR01113 2 x 5.0 nmol
EUR 394.8

rno-miR-137-5p miRNA Antagomir

MNR01114 2 x 5.0 nmol
EUR 394.8

rno-miR-137-3p miRNA Inhibitor

MIR01113 2 x 5.0 nmol
EUR 211.2

rno-miR-137-5p miRNA Inhibitor

MIR01114 2 x 5.0 nmol
EUR 211.2

mmu-miR-137-3p miRNA Inhibitor

MIM01173 2 x 5.0 nmol
EUR 211.2

mmu-miR-137-5p miRNA Inhibitor

MIM01174 2 x 5.0 nmol
EUR 211.2

mmu-miR-137-3p miRNA Antagomir

MNM01173 2 x 5.0 nmol
EUR 394.8

mmu-miR-137-5p miRNA Antagomir

MNM01174 2 x 5.0 nmol
EUR 394.8

mmu-miR-137-3p miRNA Mimic

MBS8300663-10nmol 10nmol
EUR 265

mmu-miR-137-3p miRNA Mimic

MBS8300663-5nmol 5nmol
EUR 210

mmu-miR-137-3p miRNA Mimic

MBS8300663-5x10nmol 5x10nmol
EUR 1110

rno-miR-137-3p miRNA Inhibitor

MBS8297403-10nmol 10nmol
EUR 210

rno-miR-137-3p miRNA Inhibitor

MBS8297403-20nmol 20nmol
EUR 265

rno-miR-137-3p miRNA Inhibitor

MBS8297403-5x20nmol 5x20nmol
EUR 1110

rno-miR-137-5p miRNA Mimic

MBS8302970-10nmol 10nmol
EUR 265

rno-miR-137-5p miRNA Mimic

MBS8302970-5nmol 5nmol
EUR 210

rno-miR-137-5p miRNA Mimic

MBS8302970-5x10nmol 5x10nmol
EUR 1110

rno-miR-137-5p miRNA Inhibitor

MBS8297723-10nmol 10nmol
EUR 210

Special complications depend either on the type of surgery (laparoscopic assisted, conventional open surgery) or the techniques employed (stapled, hand sutured). Handling of the tissue also plays a major role (e.g. dry versus wet pads).